HIF1A and non-small cell lung carcinoma: Interestingly, it was found that inhibition of the OLFM4/HIF-1α axis could improve hypoxia-induced invasion, epithelial-mesenchymal transition, and chemotherapy resistance of non-small-cell lung cancer [18].